# Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study

> **NCT05086523** · PHASE1,PHASE2 · UNKNOWN · sponsor: **BackBeat Medical Inc** · enrollment: 28 (estimated)

## Conditions studied

- Hypertension,Essential
- Systolic Hypertension

## Interventions

- **DEVICE:** Programmable Hypertension Control (BackBeat Moderato)
- **DEVICE:** Pacing (BackBeat Moderato)

## Key facts

- **NCT ID:** NCT05086523
- **Lead sponsor:** BackBeat Medical Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-27
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-09-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05086523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05086523, "Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05086523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*